Table 1 Group-wise demographic and clinical characteristics of all patients included in 24-h EDA pattern analysis.
From: Seizure-related differences in biosignal 24-h modulation patterns
No-seizure group (n = 68) | Seizure group (n = 49) | p-value | |
|---|---|---|---|
Sex | 0.098 | ||
Male | 30 (44.1%) | 30 (61.2%) | |
Female | 38 (55.9%) | 19 (38.8%) | |
Age at enrollment | 0.019 | ||
In years, median (IQR, p25-p75) | 9.4 (8.4, 7.0–15.4) | 13.2 (7.2, 9.6–16.8) | |
Age at First Seizure | 0.021 | ||
In years, median (IQR, p25-p75) | 3.5 (5.9, 1.1–7.0) | 7.0 (8.5, 2.0–10.5) | |
Seizure frequency (estimated per 30 days) | 0.839 | ||
No per month (IQR, p25-p75) | 4.0 (20.3, 0.7–20.9) | 4.0 (9.7, 1.0–10.7) | |
Etiology of epilepsy | 0.219 | ||
Structural | 22 (32%) | 23 (47%) | |
Unknown | 36 (53%) | 20 (41%) | |
Genetic | 6 (9%) | 3 (6%) | |
Immune | 1 (2%) | 2 (4%) | |
Infectious | 0 (0%) | 1 (2%) | |
Metabolic | 0 (0%) | 0 (0%) | |
Not Reported | 3 (4%) | 0 (0%) | |
Interictal EEG* | |||
Normal | 18 (26%) | 4 (8%) | 0.097 |
Spikes | 55 (81%) | 43 (88%) | 0.320 |
Focal Slowing | 14 (21%) | 23 (47%) | 0.002 |
Generalized Slowing | 10 (15%) | 0 (0%) | 0.005 |
MRI Findings | 0.050 | ||
Normal | 20 (29%) | 6 (12%) | |
Abnormal | 33 (49%) | 25 (51%) | |
Not done/not available | 15 (22%) | 18 (37%) | |
Reduction of at least 1 ASM during EMU stay | 0.001 | ||
Yes | 18 (26%) | 31 (63%) | |
No | 46 (68%) | 18 (37%) | |
Not available | 4 (6%) | 0 (0%) | |
Wristband Location** | 0.350 | ||
Left wrist | 18 | 13 | |
Left ankle | 18 | 18 | |
Left unavailable | 3 | 0 | |
Right wrist | 17 | 13 | |
Right ankle | 11 | 4 | |
Right unavailable | 1 | 0 | |
Unavailable | 0 | 1 | |
Recording length in hours (after 10 min segment exclusion) | 0.014 | ||
Mean (p25-p75) | 20.94 (18.5–23.0) | 19.33 (17.0–21.3) | |
